The Journal of Immunology, Vol 155, Issue 7 3385-3400, Copyright © 1995 by American Association of Immunologists

ARTICLES

Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway

PK Mongini, PF Highet and JK Inman
Department of Rheumatology and Molecular Medicine, Hospital for Joint Diseases, New York, NY 10003, USA.

Given the range of mIg-binding affinities expressed by Ag-specific B cells, the ligand:receptor affinity threshold for achieving full B cell activation via the mIgM-mediated signaling pathway is quite high. Several recombinant, or semi-purified, cytokines were found to reduce the very high mIgM:ligand affinity threshold for induction of human B cell S phase entry by bivalent, affinity-diverse anti-IgM mAbs without notably affecting the lower affinity threshold for G1-related RNA synthesis. Two-stage culture experiments suggested that one major means by which IL-4, IL-2, and low m.w. B cell growth factor lower the affinity threshold for S phase entry is an indirect one, i.e., rescue of B cells whose mIg engagements with Ag are of sufficient affinity for achieving G1 entry, but of insufficient affinity for initiating the late-phase mIgM-mediated signals needed for the G1-->S phase transition. IL-4 had additional effects in early G1. In contrast to the above cytokines, IFN-gamma, did not function as an independent cell cycle progression factor, but rather required the concomitant presence of mIgM-cross-linking ligand for enhancement. A greater potential of multivalent anti-IgM-dextran conjugates to trigger S phase entry in the absence of cytokines was found to reflect a greater potential for initiating mIgM signals during the late phase in B cell activation. The results indicate that progression of mIgM receptor-activated B cells past a G1-->S phase restriction point is dependent upon continued signal transduction via either the mIgM receptor and/or a cytokine receptor signaling pathway. When mIgM-engaging ligands are ineffective at initiating late-phase signals, due to limited size and binding site valency and/or affinity, ancillary signal transduction through cytokine receptors becomes most relevant.

This article has been cited by other articles:

				P. K. A. Mongini, J. K. Inman, H. Han, R. J. Fattah, S. B. Abramson, and M. Attur APRIL and BAFF Promote Increased Viability of Replicating Human B2 Cells via Mechanism Involving Cyclooxygenase 2. J. Immunol., June 1, 2006; 176(11): 6736 - 6751. [Abstract] [Full Text] [PDF]

				P. K. A. Mongini, J. K. Inman, H. Han, S. L. Kalled, R. J. Fattah, and S. McCormick Innate Immunity and Human B Cell Clonal Expansion: Effects on the Recirculating B2 Subpopulation J. Immunol., November 1, 2005; 175(9): 6143 - 6154. [Abstract] [Full Text] [PDF]

				P. K.A. Mongini, Q. Liu, M. A. Vilensky, P. F. Highet, and J. K. Inman Evidence for an Upper Affinity Threshold for Anti-IgM-Induced Apoptosis in a Human B-Cell Lymphoma Blood, November 15, 1998; 92(10): 3756 - 3771. [Abstract] [Full Text] [PDF]

				R. Kaposzta, P. Tree, L. Marodi, and S. Gordon Characteristics of Invasive Candidiasis in Gamma Interferon- and Interleukin-4-Deficient Mice: Role of Macrophages in Host Defense against Candida albicans Infect. Immun., April 1, 1998; 66(4): 1708 - 1717. [Abstract] [Full Text] [PDF]